A Zebrafish Model of 5q-Syndrome Using CRISPR/Cas9 Targeting RPS14 Reveals a p53-Independent and p53-Dependent Mechanism of Erythroid Failure
Authors:
- 1 May 2016
- journal article
- Published by Elsevier in Journal of Genetics and Genomics
- Vol. 43 (5) , 307-318
Abstract
No abstract availableKeywords
Funding Information
- Celgene (Nov022011)
- National Institutes of Health (R56 DK107286)
This publication has 25 references indexed in Scilit:
- Genome editing with RNA-guided Cas9 nuclease in Zebrafish embryosCell Research, 2013
- The Role of Haploinsufficiency of rps14 and p53 Activation in the Molecular Pathogenesis of the 5q- SyndromePediatric Reports, 2011
- New insights into 5q- syndrome as a ribosomopathyCell Cycle, 2010
- A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q– syndromeNature Medicine, 2009
- Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein familyBlood, 2008
- Gene expression profiling of CD34+ cells in patients with the 5q− syndromeBritish Journal of Haematology, 2007
- Narrowing and genomic annotation of the commonly deleted region of the 5q− syndromeBlood, 2002
- The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemiaNature Genetics, 1999
- Intraembryonic hematopoietic cell migration during vertebrate development.Proceedings of the National Academy of Sciences, 1995
- Molecular Mapping of Uncharacteristically Small 5q Deletions in Two Patients with the 5q- Syndrome: Delineation of the Critical Region on 5q and Identification of a 5q- BreakpointGenomics, 1994